A randomized, double-blind, multicenter comparison study of triple antiplatelet therapy with dual antiplatelet therapy to reduce restenosis after drug-eluting stent implantation in long coronary lesions: results from the DECLARE-LONG II (Drug-Eluting Stenting Followed by Cilostazol Treatment Reduces Late Restenosis in Patients with Long Coronary Lesions) trial.

Saved in:
Bibliographic Details
Title: A randomized, double-blind, multicenter comparison study of triple antiplatelet therapy with dual antiplatelet therapy to reduce restenosis after drug-eluting stent implantation in long coronary lesions: results from the DECLARE-LONG II (Drug-Eluting Stenting Followed by Cilostazol Treatment Reduces Late Restenosis in Patients with Long Coronary Lesions) trial.
Authors: Lee SW (AUTHOR), Park SW (AUTHOR), Kim YH (AUTHOR), Yun SC (AUTHOR), Park DW (AUTHOR), Lee CW (AUTHOR), Kang SJ (AUTHOR), Park SJ (AUTHOR), Lee JH (AUTHOR), Choi SW (AUTHOR), Seong IW (AUTHOR), Lee NH (AUTHOR), Cho YH (AUTHOR), Shin WY (AUTHOR), Lee SJ (AUTHOR), Hyon MS (AUTHOR), Bang DW (AUTHOR), Choi YJ (AUTHOR), Kim HS (AUTHOR), Lee BK (AUTHOR)
Source: Journal of the American College of Cardiology (JACC). Mar2011, Vol. 57 Issue 11, p1264-1270. 7p.
Database: Academic Search Ultimate
Description
ISSN:07351097
DOI:10.1016/j.jacc.2010.10.035